55 related articles for article (PubMed ID: 33539938)
1. Targeting eukaryotic elongation factor-2 kinase suppresses the growth and peritoneal metastasis of ovarian cancer.
Erdogan MA; Ashour A; Yuca E; Gorgulu K; Ozpolat B
Cell Signal; 2021 May; 81():109938. PubMed ID: 33539938
[TBL] [Abstract][Full Text] [Related]
2. A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFR.
Lau TS; Chan LK; Wong EC; Hui CW; Sneddon K; Cheung TH; Yim SF; Lee JH; Yeung CS; Chung TK; Kwong J
Oncogene; 2017 Jun; 36(25):3576-3587. PubMed ID: 28166193
[TBL] [Abstract][Full Text] [Related]
3. Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer.
Kitami K; Yoshihara M; Koya Y; Sugiyama M; Iyoshi S; Uno K; Mogi K; Tano S; Fujimoto H; Nawa A; Kikkawa F; Kajiyama H
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371469
[TBL] [Abstract][Full Text] [Related]
4. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.
Song M; Yeku OO; Rafiq S; Purdon T; Dong X; Zhu L; Zhang T; Wang H; Yu Z; Mai J; Shen H; Nixon B; Li M; Brentjens RJ; Ma X
Nat Commun; 2020 Dec; 11(1):6298. PubMed ID: 33293516
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome profiling and characterization of peritoneal metastasis ovarian cancer xenografts in humanized mice.
Kang SW; Lee JY; Kang OJ; Kim YM; Choi EK; Lee SW
Sci Rep; 2024 May; 14(1):11894. PubMed ID: 38789484
[TBL] [Abstract][Full Text] [Related]
6. Identification of SAA1 as a novel metastasis marker in ovarian cancer and development of a graphene-based detection platform for early assessment.
Zhao Y; Chen Y; Wan Q; Xiao C; Guo Z; Du X; Hu Y; Zheng A; Cao Z
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16391-16406. PubMed ID: 37707574
[TBL] [Abstract][Full Text] [Related]
7. Tumor Targeting
Ijabi J; Ijabi R; Roozehdar P; Kaminsky ZA; Moradi-Sardareh H; Tehranian N; Ahmed N
Microrna; 2024 Jan; ():. PubMed ID: 38243930
[TBL] [Abstract][Full Text] [Related]
8. Dicalcin suppresses invasion and metastasis of mammalian ovarian cancer cells by regulating the ganglioside-Erk1/2 axis.
Miwa N; Hanaue M; Aoba K; Saito R; Takamatsu K
Commun Biol; 2023 Oct; 6(1):1015. PubMed ID: 37803211
[TBL] [Abstract][Full Text] [Related]
9. Epiphycan Predicts Poor Outcomes and Promotes Metastasis in Ovarian Cancer.
Deng L; Wang D; Chen S; Hu W; Zhang R
Front Oncol; 2021; 11():653782. PubMed ID: 34888227
[TBL] [Abstract][Full Text] [Related]
10. Calcium signals and potential therapy targets in ovarian cancer (Review).
Deng F; Fu M; Zhao C; Lei J; Xu T; Ji B; Ding H; Zhang Y; Chen J; Qiu J; Gao Q
Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37711071
[TBL] [Abstract][Full Text] [Related]
11. Adipose microenvironment promotes hypersialylation of ovarian cancer cells.
Fox A; Leonard GD; Adzibolosu N; Wong T; Tedja R; Sharma S; Gogoi R; Morris R; Mor G; Fehl C; Alvero AB
bioRxiv; 2024 May; ():. PubMed ID: 38798490
[TBL] [Abstract][Full Text] [Related]
12. Patient-Derived Exosomes as siRNA Carriers in Ovarian Cancer Treatment.
Shimizu A; Sawada K; Kobayashi M; Oi Y; Oride T; Kinose Y; Kodama M; Hashimoto K; Kimura T
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672564
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumour markers in ovarian cancer treatment.
Preetam S; Mondal S; Priya S; Bora J; Ramniwas S; Rustagi S; Qusty NF; Alghamdi S; Babalghith AO; Siddiqi A; Malik S
Clin Chim Acta; 2024 Jun; 559():119687. PubMed ID: 38663473
[TBL] [Abstract][Full Text] [Related]
14. The Role of Genistein and its Derivatives in Ovarian Cancer: New Perspectives for Molecular Mechanisms and Clinical Applications.
Chaichian S; Nikfar B; Bidgoli SA; Moazzami B
Curr Med Chem; 2023 Oct; ():. PubMed ID: 37921172
[TBL] [Abstract][Full Text] [Related]
15. AKAP8 promotes ovarian cancer progression and antagonizes PARP inhibitor sensitivity through regulating hnRNPUL1 transcription.
Mobet Y; Wang H; Wei Q; Liu X; Yang D; Zhao H; Yang Y; Ngono Ngane RA; Souopgui J; Xu J; Liu T; Yi P
iScience; 2024 May; 27(5):109744. PubMed ID: 38711442
[TBL] [Abstract][Full Text] [Related]
16. Research progress in intratumoral heterogeneity and clinical significance of ovarian cancer.
Pu T; Zhang C; Su B; Li L; Fu J
Medicine (Baltimore); 2024 Jan; 103(4):e36074. PubMed ID: 38277565
[TBL] [Abstract][Full Text] [Related]
17. Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer.
Wang J; Ford JC; Mitra AK
Biology (Basel); 2023 Dec; 12(12):. PubMed ID: 38132318
[TBL] [Abstract][Full Text] [Related]
18. ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer.
Gorur A; Bayraktar R; Ivan C; Mokhlis HA; Bayraktar E; Kahraman N; Karakas D; Karamil S; Kabil NN; Kanlikilicer P; Aslan B; Tamer L; Wang Z; Cristini V; Lopez-Berestein G; Calin G; Ozpolat B
Mol Ther Nucleic Acids; 2021 Mar; 23():930-943. PubMed ID: 33614241
[TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
Zhang R; Zhu Q; Yin D; Yang Z; Guo J; Zhang J; Zhou Y; Yu JJ
Front Oncol; 2020; 10():597569. PubMed ID: 33614483
[TBL] [Abstract][Full Text] [Related]
20. Development and verification of an immune-related gene pairs prognostic signature in ovarian cancer.
Zhang B; Nie X; Miao X; Wang S; Li J; Wang S
J Cell Mol Med; 2021 Mar; 25(6):2918-2930. PubMed ID: 33543590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
